BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
May 5, 2004
View Archived Issues
Peptech, Agenix Merging In Effort To Create Australian Powerhouse
SYDNEY, Australia - Two biotech companies agreed to a share-swap merger in what they declare is the first move in building Australia's biggest pure biotech company, with more acquisitions to come. (BioWorld International)
Read More
Serono Secures Rights To 4SC Program In Autoimmune Disease
Read More
Work On Telomere Mechanism Opens New Avenues Of Research
Read More
NicOx, Ferrer Enter Collaboration To Develop Dermatology Drugs
Read More
Genmab Moving HuMax-CD4 Into Pivotal Program In CTCL
Read More
Swedish Biotech Group Decries State Of The Industry In Country
Read More
Aptanomics, Nanosyn Enter Deal To Discover Drugs For Cancer
Read More
Pharming Moves rhC1INH Into Pivotal Study In Angioedema
Read More
Prana Draws $20M Investment Following Trial In Alzheimer's
Read More
Innogenetics, Third Wave Enter Distribution Pact For Europe
Read More
Scancell Gains Interim Funding For ImmunoBody Technology
Read More
Glycoform Secures Funding For Work In Carbohydrate Delivery
Read More
Other News To Note
Read More